With health. The European Medicines Agency (EMA) has promoted a guide with which it intends to achieve better supervision and management of the safety of biological medicines in order to "optimize the safe and effective use of these products in Europe". This is thus a new chapter within the guidelines on good pharmacovigilance practices that this body usually carries out to "ensure the robustness of the safety monitoring system."
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
